- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05330936
Comparison of Cyanocobalamin in Avocado Oil Cream With Steroid Combination Ointment
May 22, 2023 updated by: Ishtiaq Ahmed, Pak Emirates Military Hospital
Comparison of Cyanocobalamin in Avocado Oil Cream With Steroid Combination Ointment in the Treatment of Chronic Plaque Psoriasi-A Randomized Clinical Trial in Tertiary Care Hospital
A randomized clinical trial with two groups. Group A Group B Group A is being treated with conventional Steroid combination ointment for the treatment of chronic Plaque Psoriasis.
Group B is being treated with Cyanocobalamin in Avocado Oil cream for the treatment of chronic Plaque Psoriasis.
Each group having 45 patients.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Outcome is being measured by PASI Score calculation with monthly follow up.
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Rawalpindi, Punjab, Pakistan, 92
- PakEmiratesMH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 60 years (Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Age bracket (18-60 years)
- Non psoriatic Arthritis
- No oral Retinoids
Exclusion Criteria:
- pregnancy
- Malignancy
- Body surface area involving >50%
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Group A
Steroid combination ointment in the treatment of chronic Plaque Psoriasis
|
Cyanocobalamin in Avocado Oil Cream
|
|
Active Comparator: Group B
Cyanocobalamin in Avocado Oil cream in the treatment of chronic Plaque
|
Cyanocobalamin in Avocado Oil Cream
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Efficacy and tolerability of steroids as compared to Avacado Oil Cream
Time Frame: 12 weeks
|
Compariaon of Efficacy of Steroid combination ointment in the treatment of chronic Plaque Psoriasis
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Qamar ud din Khan, MBBS,FCPS, Pak Emirates Military Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2021
Primary Completion (Actual)
September 1, 2022
Study Completion (Actual)
September 1, 2022
Study Registration Dates
First Submitted
March 23, 2022
First Submitted That Met QC Criteria
April 10, 2022
First Posted (Actual)
April 15, 2022
Study Record Updates
Last Update Posted (Actual)
May 24, 2023
Last Update Submitted That Met QC Criteria
May 22, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PakEmiratesMH
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Plaque Psoriasis
-
Usynova Pharmaceuticals Ltd.RecruitingPlaque Psoriasis | Moderate to Severe Plaque PsoriasisChina
-
Qilu Pharmaceutical Co., Ltd.Recruiting
-
Xiangya Hospital of Central South UniversityNot yet recruiting
-
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.MC2 TherapeuticsRecruiting
-
Beijing InnoCare Pharma Tech Co., Ltd.Recruiting
-
Haisco Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Sun Pharmaceutical Industries, Inc.CompletedPlaque PsoriasisUnited States
-
UCB Biopharma SRLActive, not recruitingModerate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque PsoriasisUnited States, Canada, Puerto Rico
-
Oruka Therapeutics, Inc.RecruitingPlaque PsoriasisUnited States, Canada
-
Oruka Therapeutics, Inc.RecruitingPlaque PsoriasisUnited States, Canada
Clinical Trials on Potent topical steroid
-
University Hospitals Coventry and Warwickshire...University Hospital, GenevaTerminatedTopical Corticosteroid-treated Dermatology Patients | Intra-ocular PressureUnited Kingdom
-
Assiut UniversityNot yet recruiting
-
Assiut UniversityUnknown
-
SanofiRegeneron PharmaceuticalsCompletedNeurodermatitisUnited States, Canada, Chile, France, Hungary, Italy, Portugal, Spain, Taiwan, United Kingdom, South Korea
-
SanofiRegeneron PharmaceuticalsCompletedNeurodermatitisFrance, United States, Argentina, China, Japan, Mexico, Russia, South Korea
-
Jordan University of Science and TechnologyCompleted
-
Rockefeller UniversityCompleted
-
University of ArizonaCompletedActinic KeratosesUnited States
-
University of NebraskaTeva Branded Pharmaceutical Products R&D, Inc.WithdrawnMultiple SclerosisUnited States
-
Universidad de AntioquiaINNOVATION CORPORATION FOR THE DEVELOPMENT OF PRODUCTS FOR TROPICAL DISEASES... and other collaboratorsWithdrawnLeishmaniasis, CutaneousColombia